Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cherry Imaging is a medical technology company specializing in high-precision 3D imaging and data analysis for the aesthetics and dermatology sectors. The company's core platform, the Trace system, provides objective, quantitative measurements of skin surface changes, allowing practitioners to track the effectiveness of treatments such as fillers, toxins, and skin rejuvenation procedures. By utilizing advanced algorithms, Cherry Imaging transforms qualitative visual assessments into reliable clinical data, supporting both aesthetic practices and clinical research. Their technology is designed to enhance patient consultation, treatment planning, and long-term follow-up through standardized 3D visualization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cherry Imaging.